Filed: 5/8/2026ACC: 0001172661-26-001629
📋 What this filing means
AIHC CAPITAL MANAGEMENT LTD filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $119.67M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$119.67M
Total AUM (reported)
5.63M
Total Shares
Allocation by class
COM$114.10M95.3%
SPONSORED ADS$5.57M4.7%
Portfolio Concentration
Top 3$117.35M98.1%
4–10$2.32M1.9%
Top 3 weight
98.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 5.63M
Sole
Full voting authority
5.63M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
REVOLUTION MEDICINES INC
SOLEShares828.97K
TypeSH
Market value$80.62M
67.37%
Sole
828.97K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.46M
TypeSH
Market value$31.16M
26.04%
Sole
2.46M
Shared
0.00
None
0.00
NOVABRIDGE BIOSCIENCES
SOLEShares2.26M
TypeSH
Market value$5.57M
4.65%
Sole
2.26M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares51.40K
TypeSH
Market value$1.98M
1.65%
Sole
51.40K
Shared
0.00
None
0.00
KORRO BIO INC
SOLEShares30.27K
TypeSH
Market value$342.6K
0.29%
Sole
30.27K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 828.97K | SH | $80.62M 67.37% | 828.97K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.46M | SH | $31.16M 26.04% | 2.46M | 0.00 | 0.00 |
NOVABRIDGE BIOSCIENCESSOLE | SPONSORED ADS | 2.26M | SH | $5.57M 4.65% | 2.26M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 51.40K | SH | $1.98M 1.65% | 51.40K | 0.00 | 0.00 |
KORRO BIO INCSOLE | COM | 30.27K | SH | $342.6K 0.29% | 30.27K | 0.00 | 0.00 |